Bacteremia in Cancer Patients with Febrile Neutropenia in Uganda
Author Information
Author(s): Lubwama Margaret, Holte Sarah E, Zhang Yuzheng, Mubiru Kelvin R, Katende George, Orem Jackson, Kateete David P, Bwanga Freddie, Phipps Warren
Primary Institution: Makerere University, Kampala, Uganda
Hypothesis
What are the etiology, risk factors, and outcomes associated with bacteremia in patients with hematologic malignancies and febrile neutropenia?
Conclusion
Bacteremia was frequent in patients with hematologic cancer and febrile neutropenia and was associated with poor survival.
Supporting Evidence
- 33% of participants with febrile neutropenia had bacteremia.
- 30-day overall survival for participants with bacteremia was significantly lower than for those without.
- 86% of bacteremia episodes were caused by multidrug-resistant bacteria.
Takeaway
This study found that many cancer patients in Uganda get serious infections called bacteremia, which can make them very sick and lead to death.
Methodology
A prospective cohort study was conducted with adult and pediatric inpatients with hematologic malignancies and febrile neutropenia, followed for 30-day mortality.
Potential Biases
Potential bias due to the study being conducted at a single center and focusing only on hematologic malignancies.
Limitations
The study was limited to a single institution and may not be generalizable to other settings.
Participant Demographics
Median age was 23 years, with 62% male participants.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website